NCT04655352View on ClinicalTrials.gov

Safety and Tolerability of Bacillus Subtilis MB40 in Healthy Adult Volunteers

CompletedOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

October 28, 2015

Primary Completion Date

December 17, 2015

Study Completion Date

December 17, 2015

Conditions

Healthy Participants

Interventions

DIETARY_SUPPLEMENT

Bacillus subtilis MB40

1-week placebo (maltodextrin and excipients) lead-in followed by 250 mg capsule (5 billion CFU/capsule) administered twice daily for 21 days

Sponsors

Collaborators (1)

Prism Research LLC

All Listed Sponsors

collaborator

Prism Research LLC

UNKNOWN

lead

BIO-CAT Microbials, LLC

INDUSTRY